Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Electrum Identifies New Mineralised Trends and Refines Targeting with Magnetic Survey (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
sarimeth
X
Comment by
sarimeth
on Oct 08, 2024 12:23pm
RE:RE:RE:Double From Here?
he is just sharing his worthless honest opinions.......
(79)
•••
BlueJay2020
X
Comment by
BlueJay2020
on Oct 08, 2024 11:27am
RE:RE:Double From Here?
What matters to me is that I am making a very nice return on this stock - up 12% since my first purchase 3 months ago. How about you?
(12)
•••
raybay_98
X
Comment by
raybay_98
on Oct 08, 2024 10:02am
RE:Double From Here?
Ever heard of 'Out To Lunch'. I believe Scotia has had that target for a long long time. Mind you, it just might get there in 20 years! jmho
(6173)
•••
retiredcf
X
Post by
retiredcf
on Oct 08, 2024 7:39am
Double From Here?
It's actually more than a double according to this analyst. GLTA Scotia’s George Farmer raised his DRI Healthcare Trust (DHT.UN-T) target to US$22 from US$21 with a “sector outperform
...more
(69)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Oct 07, 2024 5:51pm
RE:RBC 2
Thx retiredcf! My broker just added these PT updates: Stifel $16 Bloom $20.20 Canaccord $18 No info provided on changes. Canaccord curiously described as initiated -- I recall the analyst
...more
(6173)
•••
retiredcf
X
Post by
retiredcf
on Oct 07, 2024 9:14am
RBC 2
Their upside scenario target is now $20.00. GLTA October 6, 2024 Outperform TSX: DHT-U; CAD 13.69 Price Target CAD 16.00
...more
(12)
•••
raybay_98
X
Post by
raybay_98
on Oct 04, 2024 11:08am
Going No Where Fast!
Oh my my! jmho
(6173)
•••
retiredcf
X
Post by
retiredcf
on Oct 04, 2024 9:28am
CIBC Report
EQUITY RESEARCH October 3, 2024 Earnings Update DRI HEALTHCARE TRUST Acquiring Payment Streams Based On CASGEVY For $57MM Our Conclusion DRI Healthcare announced the $57MM acquisition of a payment
...more
(6173)
•••
retiredcf
X
Post by
retiredcf
on Oct 04, 2024 9:16am
RBC
October 3, 2024 DRI Healthcare Trust First step on the new counterparty path - announces acquisition of Casgevy stream for US $57MM TSX: DHT-U |
...more
(6173)
•••
retiredcf
X
Post by
retiredcf
on Oct 04, 2024 8:53am
Back in Business
Following Thursday’s announcement of a US$57-million deal with Editas Medicine Inc. for a share of its annual license fees for the Cas9 gene-editing technology, CIBC’s Scott Fletcher raised his DRI
...more
(69)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Oct 04, 2024 8:43am
RE:RE:New Press Release - DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)
Raymond James CAD23 from 20 CIBC CAD18.5 from 17.5
(69)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Oct 03, 2024 7:00pm
RE:New Press Release - DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)
Buckle up, buttercups! Analysts took PTs down because they wanted proof that new mgmt could close deals. Proof has arrived. Will they boost their targets? Hopefully this will knock the
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 03, 2024 6:01pm
New Press Release - DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)
– Transaction adds another innovative rare disease therapy to the DHT portfolio –– Novel deal structure offers predictable annual cash flows as well as potential additional annual sales-based milestones and a one-time contingent payment –TORONTO, Oct. 3, 2024 /CNW/ - DRI Healthcare Trust (TSX...
read article.
(12)
•••
raybay_98
X
Comment by
raybay_98
on Sep 30, 2024 9:59am
RE:RE:RE:RE:RE:RE:Scotia Hearts DHT (or did today, at least)
I bet you don't get a response! jmho
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Merger Announced to Create a Leading Yukon Copper-Gold Exploration and Development Company
New Analyst Report Lifts Almonty Target Price to CDN$5.50
Graphite One and Lucid Enter into Second Non-Binding Supply Agreement
Graphite Creek Project Approved for FAST-41 Federal Permitting Dashboard
Mullen Group acquires company expected to generate annualized revenues of $300 million
Despite turbulent markets this logistics company continues to grow